Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients Using Hybrid Digital Twin Solutions
NCT ID: NCT07131371
Last Updated: 2025-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
2500 participants
OBSERVATIONAL
2024-01-15
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response
NCT02559726
Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic Cardiomyopathy
NCT03450252
Characterization of Arrhythmia-induced Cardiomyopathy
NCT05662293
CArdiac Desynchronization In Obstructive HCM, CARDIO-HCM
NCT01332162
Validation of Kinocardiography, a New Technology Measuring Cardiac Mechanical Activity Via Accelerometers and Gyroscopes
NCT04772807
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HCM patients from Florence Italy, Rennes, France, and Tampere Finland
HCM patients in follow up
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bologna
OTHER
Universita Degli Studi di Firenze
UNKNOWN
Rennes University Hospital
OTHER
University of Milan
OTHER
University College Dublin
OTHER
Universitätsklinikum Hamburg-Eppendorf
OTHER
Medtronic Bakken Research
INDUSTRY
Pharmatics Limited
UNKNOWN
University of Oxford
OTHER
University of Rennes 2
OTHER
Tampere University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katriina Aalto-Setälä
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jari Hyttinen, Professor
Role: STUDY_DIRECTOR
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tampere university
Tampere, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
101137115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.